These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Review of Data and Discussion - Who Should Undergo Patent Foramen Ovale Closure in 2014? Bhan A; Clapp B Interv Cardiol; 2014 Apr; 9(2):115-120. PubMed ID: 29588788 [TBL] [Abstract][Full Text] [Related]
4. Patent foramen ovale closure in the management of cryptogenic stroke: a review of current literature and guideline statements. Elzanaty AM; Patel N; Sabbagh E; Eltahawy EA Curr Med Res Opin; 2021 Mar; 37(3):377-384. PubMed ID: 33460329 [TBL] [Abstract][Full Text] [Related]
5. To close or not to close: contemporary indications for patent foramen ovale closure. Zier LS; Sievert H; Mahadevan VS Expert Rev Cardiovasc Ther; 2016 Nov; 14(11):1235-1244. PubMed ID: 27616622 [TBL] [Abstract][Full Text] [Related]
9. Persistent pathology of the patent foramen ovale: a review of the literature. Cho KK; Khanna S; Lo P; Cheng D; Roy D Med J Aust; 2021 Jul; 215(2):89-93. PubMed ID: 34218432 [TBL] [Abstract][Full Text] [Related]
10. A matching-adjusted indirect comparison of results from REDUCE and RESPECT-two randomized trials on patent foramen ovale closure devices to prevent recurrent cryptogenic stroke. Kasner SE; Sondergaard L; Nakum M; Gomez Montero M; Hashim M; Landaas EJ J Med Econ; 2024; 27(1):337-343. PubMed ID: 38373018 [TBL] [Abstract][Full Text] [Related]
11. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials. Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192 [TBL] [Abstract][Full Text] [Related]
12. Intermediate and long-term results of transcatheter closure of patent foramen ovale using the amplatzer patent foramen ovale occluder: one case of pulmonary embolism irrespective of patent foramen ovale closure. Yoon JH; Kim JS; Lee DH; Shim EJ; Lee SY; Min KS; Cho DJ; Lee HR Korean Circ J; 2011 Jul; 41(7):356-62. PubMed ID: 21860636 [TBL] [Abstract][Full Text] [Related]
13. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial. Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L; JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037 [TBL] [Abstract][Full Text] [Related]
18. Impaired endothelial function in patients with cryptogenic stroke and patent foramen ovale is not affected by closure. Lantz M; Kostulas K; Settergren M; Sjöstrand C J Interv Cardiol; 2017 Jun; 30(3):242-248. PubMed ID: 28439982 [TBL] [Abstract][Full Text] [Related]
19. [Percutaneous closure of patent foramen ovale: a wise approach]. Gaspardone A; Iani C; Papa M G Ital Cardiol (Rome); 2008 Sep; 9(9):593-602. PubMed ID: 18783080 [TBL] [Abstract][Full Text] [Related]
20. Role of closure of patent foramen ovale in cryptogenic stroke: Current status. Abhishek BS; Bhambhani A Natl Med J India; 2017; 30(5):268-271. PubMed ID: 29916427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]